AWM
MRNA icon

Altium Wealth Management’s Moderna MRNA Stock Holding History

Altium Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$575K Sell
4,026
-593
-13% -$84.8K 0.04% 216
2022
Q1 		$796K Buy
4,619
+2,471
+115% +$416K 0.05% 186
2021
Q4 		$546K Buy
+2,148
New +$628K 0.04% 234

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Altium Wealth Management's MRNA Position: Q2 2022 in Review

Altium Wealth Management reduced its Moderna (MRNA) stake by 13% in Q2 2022, selling an estimated $84.8K and leaving 4,026 shares worth $575K. The position accounts for 0.04% of the portfolio, ranked #216.

Altium Wealth Management first reported a position in MRNA in Q4 2021 and has held it in 3 quarters since. The position peaked at $796K in Q1 2022. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Altium Wealth Management held 4,026 shares of Moderna worth $575K as of Q2 2022.
  • Altium Wealth Management sold 593 Moderna shares in Q2 2022, an estimated $84.8K.
  • Moderna made up 0.04% of Altium Wealth Management's portfolio in Q2 2022, its #216 holding.
  • Altium Wealth Management first reported a position in Moderna in Q4 2021 and has held it in 3 quarters since.
  • Altium Wealth Management's Moderna position peaked at $796K in Q1 2022.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Altium Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.